Mast Therapeutics, Inc. (MSTX)

[lux1]

EPIC, again. What really happened? Trial failed, a fact that seems accepted by all longs also if with huge losses.
But, Sorry, I just can't shake the idea of that the Vepoloxamer results showed. Before the data we were talking about the possible results: if good, average, borderline or too weak to pass,all based on previous P2/P3 trials, on recent studies and articles published at ASH. Against all expectations, including
negative, the data were not only insufficient to pass but also nil and even pejorative vs placebo. Very,very strange.
A so exaggerated bad result that can't be explained with all researchers have been seen for years. I ask what really happened?
Can we with certainty rule out the suspicion of a confuse use of drug and placebo?